FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:126-127 July 9, 1998 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Estacio, R. O.

To the Editor: Estacio et al. (March 5 issue)¹ report an increased incidence of fatal and nonfatal myocardial infarction in patients with hypertension and diabetes who received nisoldipine, in a randomized, prospective, blinded study of moderate as compared with intensive control of hypertension and nisoldipine as compared with enalapril. The increased incidence of fatal and nonfatal myocardial infarction could be due to a deleterious effect of nisoldipine, a protective role of enalapril, or both, but the study design does not allow for further conclusions. Since, as the authors state, the incidence of myocardial infarction in the nisoldipine group was not . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.